If you liked this article you might like

Week Ahead: Earnings Season Enters Week Three With Apple and Alphabet on Tap
'Mad Money' Lightning Round: Starwood Not So Hot, But Expedia Looks Good
Jim Cramer's 'Mad Money' Recap: Takeover Talk Distracts From Earnings Focus
Gilead Sciences Advances Fatty Liver Drug, Causing Some Head-Scratching